The largest database of trusted experimental protocols

17 protocols using pcas9 gfp

1

CRISPR-Cas9 Knockout of Nrf2 in 16HBE Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
CRISPR-Cas9 technology was conducted to knockout Nrf2 gene according to the protocol from Dr. Zhang F. The two sgRNAs targeting human Nrf2 were designed and constructed into pSgRNA (addgene#47108) using Bbs1 digestion (sgRNA sequences, F1:CAATTAAGGCATGGAATTCCCAT, R1: AAACCTATTCCCAGAGTCAGTCA; F2: CATTCCTCCAGGACCCTAGGATGCAGT, R2: AAACGTTCGAACTCTGAC-GGTA). In addition, the constructed plasmids and pCas9-GFP (addgene#44719) were transfected into 16HBE cells by Lipofectamine 3000 transfection reagent (#13778150, Invitrogen, USA) according to the manufacturer’s instructions. Approximately 1 × 106 cells were transfected with 1 μg pCas9 plasmids, 1 μg pSgRNAs, and 0.2 μg PKG-puro plasmid with puromycin resistance gene. Puromycin (1.5 μg/ml) was then co-cultured with cells to select puromycin resistance cells. Total proteins were then extracted from the cells and Western Blot was used to verify the transfection efficiency of the plasmids.
+ Open protocol
+ Expand
2

Gene Editing of Isogenic iPSC Pairs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Gene editing of isogenic iPSC pairs was performed in collaboration with the Harvard Stem Cell Institute iPSC Core Facility. Briefly, the FA0000011 control iPSC line was characterized for morphology and pluripotency at passage 13 (Supplementary Data 1) and transfected with pCas9GFP (pCas9GFP was a gift from Kiran Musunuru, Addgene plasmid # 44719; http://n2t.net/addgene:44719; RRID: Addgene_44719)101 (link) and independent guide RNAs cloned into pSPgRNA (pSPgRNA was a gift from Charles Gersbach, Addgene plasmid # 47108; http://n2t.net/addgene:47108; RRID: Addgene_47108; see Supplementary Table 2 for list of guide RNAs used)102 (link) using Lipofectamine 3000. GFP-positive cells were sorted and seeded at low density until single cell-derived colonies were formed. Clones were picked and cultured in a 96-well plate format for analysis of target mutations by Sanger DNA sequencing. Clones with a single point mutation in one of the target gene alleles and no modifications to the opposing allele were selected as heterozygous mutants and clones without any detectable modifications in any of the alleles of the target gene were selected as paired controls.
+ Open protocol
+ Expand
3

CRISPR-Mediated Genome Editing of iPSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genome editing was performed utilizing a CRISPR/Cas9 protocol adapted from previous studies (Cohn et al., 2019 (link); Hinson et al., 2015 (link)). 8×106 iPSCs were electroporated with 20 μg pCas9-GFP (Addgene 44719), 20 μg of the appropriate hU6-driven sgRNA (designed using https://zlab.bio/guide-design-resources), and 20 μg of the HR targeting vector to generate ACTN2-BirA* knock-in iPSCs (Ding et al., 2013 (link)). Electroporated cells were transferred to a Matrigel-coated 100 mm dish containing mTeSR1 and 10 μM Y-27632. The following day, selection was started with 50 μg/mL Hygromycin B (Invitrogen 10687010) to isolate single iPSC clones, which were then manually picked, expanded, and screened via Sanger sequencing. Isogenic knockout of TNNT2 was performed similarly, but in the absence of an HR vector and with GFP-based FACS enrichment in place of antibiotic selection.
+ Open protocol
+ Expand
4

CRISPR-Mediated Targeted Gene Integration

Check if the same lab product or an alternative is used in the 5 most similar protocols
The pCas-9-GFP, pCas9D10A-GFP, and gRNA cloning vectors were obtained from Addgene. The traditional MEF2C FlagBio target vector containing the FlagBio ORF and Frt-Neo-Frt cassette flanked by 1 kb and 4 kb homolog arms was made by recombineering [7] (link). The dsDNA donor with 50 bp homolog arms on each side was made by PCR, using primers harboring 50 bp homology sequences. The Oct4-GFP donor with 200 bp homolog arms was made using the Gibson assembly technique [8] (link) using a kit from New England Biolabs, with pCR-Blunt II-TOPO vector (Life Technologies) as backbone.
Oligonucleotides were synthesized by Integrated DNA Technologies. Primer sequences are indicated in Table 1. gRNAs were designed using the CRISPR design tool (crispr.mit.edu) [9] (link).
+ Open protocol
+ Expand
5

Efficient Cas9/gRNA Transfection in MSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were transfected by 4D Nucleofector Amaxa technology (Lonza) using the cell line nucleofector (solution P1, FF-104) with 1 μg of plasmid pCAS9-GFP (44719; Addgene) and 1 μg of each plasmid (MLM3636, 43860; Addgene) encoding for the different gRNAs (2 μg for gRNAEWS). For Cas9/gRNA RNP complexes, MSCPat and hMPCs were transfected directly with the different combination of gRNAs and Cas9-GFP protein (ratio 2:1). gRNA sequences are listed in the Supplementary material.
+ Open protocol
+ Expand
6

Generation of CFTR Knockout 3T3-L1 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
3T3-L1 cells (ATCC) were grown in DMEM, 10% calf serum, and 1% penicillin-streptomycin, amphotericin B. 3T3-L1 cells were transfected with pCas9-GFP (Addgene), mouse CRISPR exon 11 (Invitrogen GeneArt), and template plasmid pCR2.1TOPOdeltaF508 at a 2:1:1 ratio with 60 ul of Lipofectamine 2000 (Invitrogen) per confluent 10 cm dish. After 48 hours, GFP+ cells were sorted on the FACS DIVA (Becton Dickinson). After allowing the cells to recover, clones were selected by limiting dilution and diluted to single cells in 96-well plates. After clonal expansion, clones were screened by isolating genomic DNA with the QIAamp kit (Qiagen) and PCR of mouse exon 11. The primers were exon 11 forward 5′tggacgcaagaaagggataag3′ and exon 11 reverse 5′gctgtctgcttcctgactatg3′. PCR products were gel purified using the QIAQuick gel extraction kit (Qiagen). Purified products were first sequenced by Sanger (MACLAB). Of 14 surviving clones, 2 were positive for mutations in mouse exon 11.
+ Open protocol
+ Expand
7

CRISPR-Mediated Genome Editing of iPSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genome editing was performed utilizing a CRISPR/Cas9 protocol adapted from previous studies (Cohn et al., 2019 (link); Hinson et al., 2015 (link)). 8×106 iPSCs were electroporated with 20 μg pCas9-GFP (Addgene 44719), 20 μg of the appropriate hU6-driven sgRNA (designed using https://zlab.bio/guide-design-resources), and 20 μg of the HR targeting vector to generate ACTN2-BirA* knock-in iPSCs (Ding et al., 2013 (link)). Electroporated cells were transferred to a Matrigel-coated 100 mm dish containing mTeSR1 and 10 μM Y-27632. The following day, selection was started with 50 μg/mL Hygromycin B (Invitrogen 10687010) to isolate single iPSC clones, which were then manually picked, expanded, and screened via Sanger sequencing. Isogenic knockout of TNNT2 was performed similarly, but in the absence of an HR vector and with GFP-based FACS enrichment in place of antibiotic selection.
+ Open protocol
+ Expand
8

Targeted Gene Editing in Smad3-/- ES Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
1 × 106 Smad3−/− ES cells were washed twice with PBS, resuspended in 150 μl of Amaxa electroporation reagents, and mixed with 5 μg Rosa26 gRNA, 5 μg pCas9-GFP (addgene, 44719) and 40 μg individual donor plasmids. After incubating in 0.4 cm cuvette (Bio-Rad) on ice for 5 mins, cells were subjected to electroporation (Bio-Rad, Gene Pulser Xcell Total System) at 320 v, 200 μF and ∞ Ω. The electroporated cells were then cultured on irradiated MEF in DMEM with 15%FBS. Recombinated cells expanded under 5 μg/ml puromycin selection were kept for further biological assay.
+ Open protocol
+ Expand
9

Adenoviral Constructs for CRISPR Studies

Check if the same lab product or an alternative is used in the 5 most similar protocols
The BE3-encoding gene and synthetic polyadenylation sequence from pCMV-BE3, the CAG reporter from pCas9_GFP (Addgene plasmid #44719), and the U6 promoter-driven gRNA cassette from pGuide (Addgene plasmid #64711) with the protospacer sequence 5’-CAGGTTCCATGGGATGCTCT-3’ (for Pcsk9 studies), the protospacer sequence 5’-CATTCAACGTCACAACCACC-3’ (for the Hpd studies), or the protospacer sequence 5’-GGTGCTAGCCTTGCGTTCCG-3’ (control studies: irrelevant protospacer not matching any sequence in the mouse genome) were cloned into pDUAL-Basic expression vector. For R26mTmG/+ experiments, which used SpCas9 and not the BE3, the mTmG protospacer (5’-ATTATACGAAGTTATATTAA-3’) was cloned into plasmid pX330-U6-Chimeric_BB-CBh-hSpCas9 (a gift from Feng Zhang; Addgene plasmid # 42230). Vector Biolabs (Malvern, PA) used these constructs to generate recombinant adenovirus type 5 particles. Premade adenovirus type 5 particles containing the GFP transgene or Cre recombinase under a CMV promoter were obtained from Vector Biolabs. Ad viral vectors are referred to as Ad.BE3.Pcsk9, Ad.BE3.Hpd, Ad.BE3.Null, Ad.SpCas9.mTmG, Ad.GFP, and Ad.Cre, and the titers are indicated in Supplementary Table 2.
+ Open protocol
+ Expand
10

Cas9 and Base Editing Plasmid Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following Cas9 plasmids were used: pCas9_GFP (Addgene #44719), hCas9 (Addgene #41815). Base editing plasmids used: pCMV_BE3 (Addgene #73021), pCMV_BE4 (Addgene #100802), pCMV_BE4-gam (Addgene #100806), ABE 7.10 (Addgene #102909). The gRNAs used in this study were synthesized and cloned as previously described (36 ). Briefly, two 24mer oligos with sticky ends compatible for ligation were synthesized from IDT for cloning into the pSB700 plasmid (Addgene Plasmid #64046).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!